Prestalia® (perindopril/amlodipine) – New and updated warnings
The FDA approved new and updated safety information to the Warnings and Precautions section of the Prestalia (perindopril/amlodipine) drug label, pertaining to hepatic failure and the risk of acute renal failure in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) or angiotensin receptor blockers (ARBs).
Top